» Articles » PMID: 18093542

Cryoglobulins As Indicators of Upregulated Immune Response in Schizophrenia

Overview
Journal Clin Biochem
Specialty Biochemistry
Date 2007 Dec 21
PMID 18093542
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: In the present work the concentration of abnormal immune complexes, cryoglobulins (Cgs), in the blood of schizophrenic patients was determined, and immunochemical composition of these complexes was studied.

Patients And Methods: Eighty multiple-episode schizophrenia-affected subjects (55 medicated, 25 drug-free) and 40 healthy controls were involved in the study. Cgs were isolated by exposure of blood serum samples to precipitation at low temperature followed by extensive washings of Cg-enriched pellets. The immunochemical composition of Cgs was analyzed using different electrophoretic and immunoblotting systems.

Results: Significantly increased blood serum levels of type III Cgs were detected in all schizophrenia-affected subjects, as compared to controls. We also revealed the presence of C1q and C3 complement proteins and their activation products in Cgs isolated from the blood of schizophrenic patients.

Conclusions: The results of the present study suggest that Cgs are involved in schizophrenia-associated upregulated immune response by binding the complement proteins, activating the complement cascade and triggering aberrant apoptosis.

Citing Articles

The complement system in neurodegenerative and inflammatory diseases of the central nervous system.

Negro-Demontel L, Maleki A, Reich D, Kemper C Front Neurol. 2024; 15:1396520.

PMID: 39022733 PMC: 11252048. DOI: 10.3389/fneur.2024.1396520.


Role of Immune and Autoimmune Dysfunction in Schizophrenia.

Severance E, Yolken R Handb Behav Neurosci. 2021; 23:501-516.

PMID: 33456427 PMC: 7173552. DOI: 10.1016/B978-0-12-800981-9.00029-8.


The complement system in schizophrenia: where are we now and what's next?.

Woo J, Pouget J, Zai C, Kennedy J Mol Psychiatry. 2019; 25(1):114-130.

PMID: 31439935 DOI: 10.1038/s41380-019-0479-0.


Autoimmune phenotypes in schizophrenia reveal novel treatment targets.

Severance E, Dickerson F, Yolken R Pharmacol Ther. 2018; 189:184-198.

PMID: 29742478 PMC: 6097895. DOI: 10.1016/j.pharmthera.2018.05.005.


The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Severance E, Tveiten D, Lindstrom L, Yolken R, Reichelt K Curr Pharm Des. 2016; 22(40):6076-6086.

PMID: 27634185 PMC: 5506689. DOI: 10.2174/1381612822666160914183804.